Endocrine ductal carcinoma in situ (E-DCIS) of the breast: A form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics

American Journal of Surgical Pathology

Volumn 20, Issue 8, 1996, Pages 921-943

  Tsang, William Y W ^a   Chan, John K C ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

Breast cancer; Carcinoid tumor; Colloid carcinoma; Endocrine ductal carcinoma in situ; Immunohistochemistry; Intraductal carcinoma

Indexed keywords

AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BREAST CANCER; CANCER GRADING; CARCINOID; CARCINOMA IN SITU; CLINICAL ARTICLE; CLINICAL FEATURE; COLLOID CARCINOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; SCLEROSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEUROENDOCRINE TUMORS;

EID: 0029927302     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199608000-00002     Document Type: Article

References (64)

1. Ashworth MT, Haqqani MT. Endocrine variant of ductal carcinoma in situ of breast: ultrastructural and light microscopical study. J Clin Pathol 1986;39:1355-9.
2. Azzopardi JG. Problems in breast pathology. London: WB Saunders. 1979 (Major problems in pathology; vol 11).
3. Azzopardi JG, Muretto P, Goddeeris P, Eusebi V, Lauweryns JM. 'Carcinoid' tumors of the breast: the morphological spectrum of argyrophil carcinomas. Histopathology 1982;6:549-69.
4. Bartkova J, Barnes DM, Millis RR, et al. Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ. Hum Pathol 1990;21:1164-7.
5. Bellamy COC, McDonald C, Salter DM, Chetty U, Anderson TJ. Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization. Hum Pathol 1993;24: 16-23.
6. Bobrow LG, Happerfield LC, Gregory WM, et al. The classification of ductal carcinoma in situ and its association with biological markers. Semin Diagn Pathol 1994;11:208-14.
7. Bur ME, Zimarowski MJ, Schnitt SJ, et al. Estrogen receptor immunohistochemistry in carcinoma in situ of the breast. Cancer 1992;69:1174-81.
8. Bussolati G, Gugliotta P, Sapino A, Eusebi V, Lloyd RV. Chromogranin-reactive endocrine cells in argyrophilic carcinomas ("carcinoids") and normal tissue of the breast. Am J Pathol 1985;120:186-92.
9. Bussolati G, Papotti M, Sapino A, Gugliotta P, Ghiringhello B, Azzopardi JG. Endocrine markers in argyrophilic carcinomas of the breast. Am J Surg Pathol 1987;11:248-56.
10. Capella C, Eusebi V, Mann B, Azzopardi JG. Endocrine differentiation in mucoid carcinoma of the breast. Histopathology 1980;4:613-30.
11. Clayton F. Pure mucinous carcinomas of breast: morphologic features and prognostic correlates. Hum Pathol 1986; 17:34-8.
12. Clayton F, Ordonez NG, Sibley RK, Hanssen G. Argyrophilic breast carcinomas: evidence of lactational differentiation. Am J Surg Pathol 1982;6:323-33.
13. Coady AT, Shousha S, Dawson PM, Moss M, James KR, Bull TB. Mucinous carcinoma of the breast: further characterization of its three subtypes. Histopathology 1989;15:617-26.
14. Cross AS, Azzopardi JG, Krausz T, van Noorden S, Polak JM. A morphological and immunocytochemical study of a distinctive variant of ductal carcinoma in-situ of the breast. Histopathology 1985;9:21-7.
15. Cubilla AL, Woodruff JM. Primary carcinoid tumor of the breast: a report of eight patients. Am J Surg Pathol 1977;1: 283-92.
16. Ellis IO, Elston CW. Tumors of the breast. In: Fletcher CDM, ed. Diagnostic histopathology of tumors. Edinburgh: Churchill Livingstone, 1995:632-89.
17. Erlandson RA. Diagnostic transmission electron microscopy of tumors. New York: Raven, 1994:130-1.
18. Fechner RE, Mills SE. Breast pathology: benign proliferations, atypias and in situ carcinomas. Chicago: American Society of Clinical Pathologists, 1990.
19. Fentiman IS, Fagg N, Millis RR, Hayward JL. In situ ductal carcinoma of the breast: implications of disease pattern and treatment. Eur J Surg Oncol 1986;12:261-6.
20. Ferguson DJP, Anderson TJ, Wells CA, Batterby S. An ultrastructural study of mucoid carcinoma of the breast: variability of cytoplasmic features. Histopathology 1986;10: 1219-30.
21. Festissof F, Dubois MP, Arbeille-Brassart B, et al. Argyrophilic cells in mammary carcinoma. Hum Pathol 1983;14: 127-34.
22. Fisher ER, Brown R. Intraductal signet ring carcinoma: a hitherto undescribed form of intraductal carcinoma of the breast. Cancer 1985;55:2533-7.
23. Fisher ER, Palekar AS. Solid and mucinous varieties of socalled mammary carcinoid tumor. Am J Clin Pathol 1979; 72:909-16.
24. Francois A, Chatikhine VA, Chevallier B, et al. Neuroendocrine primary small cell carcinoma of the breast: report of a case and review of the literature. Am J Clin Oncol 1995; 18:133-8.
25. Giri DD, Dundas SAC, Nottingham JF, et al. Oestrogen receptor in benign epithelial lesions and intraduct carcinomas of the breast: an immunohistological study. Histopathology 1989;15:575-84.
26. Gould VE, Lee L, Wiedenmann B, Moll R, Chejfec G, Frank WW. Synaptophysin: a novel marker for neurons, certain neuroendocrine cells, and their neoplasm. Hum Pathol 1986;17:979-83.
27. Harris M, Vasudev KS, Anfield C, Wells S. Mucin-producing carcinoma of the breast: ultrastructural observation. Histopathology 1978;2:177-88.
28. Holland R, Peterse JL, Millis RR, et al. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol 1994;11:167-80.
29. Lagios MD. Ductal carcinoma in situ: pathology and treatment. Surg Clin North Am 1990;70:853-71.
30. Lloyd RV. Immunohistochemical localization of chromogranin in normal and neoplastic endocrine tissues. Pathol Annu 1987;22(Pt 2):69-90.
31. Locker AP, Horrocks C, Gilmour AS, et al. Flow cytometric and histological analysis of ductal carcinoma in situ of the breast. Br J Surg 1990;77:564-7.
32. Maluf HM, Zukerberg LR, Dickersin GR, Koerner FC. Spindle-cell argyrophilic mucin-producing carcinoma of the breast: histological, ultrastructural, and immunohistochemical studies of two cases. Am J Surg Pathol 1991;15:677-86.
33. Meyer JS. Cell kinetics of histologic variants of in situ breast carcinoma. Breast Cancer Res Treat 1986;7:171-80.
34. Miller K, Auld J, Jessup E, Rhodes A, Ashton-Key M. Antigen unmasking in formalin-fixed routinely processed paraffin wax-embedded sections by pressure cooking: a comparison with microwave oven heating and traditional methods. Adv Anat Pathol 1995;2:60-4.
35. Millis RR, Haby AM, Girling AC. The breast. In: Stemberg SS, ed. Diagnostic surgical pathology. 2nd ed. New York: Raven, 1994:323-408.
36. Nesland JM, Memoli VA, Holm R, Gould VE, Johannessen JV. Breast carcinomas with neuroendocrine differentiation. Ultrastruct Pathol 1985;8:225-40.
37. Ottersen GL, Graverson HP, Blichert-Toft M, et al. Ductal carcinoma in situ of the female breast: short term results of a prospective study. Am J Surg Pathol 1992;16:1183-96.
38. Page DL, Anderson TJ, Rogers LW. Carcinoma in situ (CIS). In: Page DL, Anderson TJ, eds. Diagnostic histopathology of the breast. Edinburgh, U.K.: Churchill Livingstone 1987:157-92.
39. Page DL, Lagios MD. Pathologic analysis of the National Surgical Adjuvant Breast Project (NSABP) B-17 Trial: unanswered questions remaining unanswered considering current concept of ductal carcinoma in situ. Cancer 1995;75: 1219-222.
40. Papotti M, Macri L, Finzi G, Capella C, Eusebi V, Bussolati G. Neuroendocrine differentiation in carcinomas of the breast: a study of 51 cases. Semin Diagn Pathol 1989;6:174-88.
41. Papotti M, Gherardi G, Eusebi V, Pagani A, Bussolati G. Primary oat cell (neuroendocrine) carcinoma of the breast: report of four cases. Virchows Arch [A] 1992;420:103-8.
42. Partaneu S, Syrjanin K. Argyrophilic cells in carcinoma of the female breast. Virchow Arch [A] 1981;391:45-51.
43. Patchefsky AS, Schwartz GF, Finkelstein SD, et al. Heterogeneity of intraductal carcinoma of the breast. Cancer 1989; 63:731-41.
44. Poller DN, Silverstein MJ, Galea M, et al. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification: association between cellular proliferation and c-erbB-2 protein expression. Mod Pathol 1994;7: 257-62.
45. Poller DN, Roberts EC, Bell JA, et al. p53 protein expression in mammary ductal carcinoma in situ: relationship to immunohistochemical expression of oestrogen receptor and c-erbB-2 protein. Hum Pathol 1993;24:463-8.
46. Ramachandra S, Machin L, Ashley S, et al. Immunohistochemical distribution of c-erbB-2 in in-situ breast carcinoma: a detailed morphological analysis. J Pathol 1990;161:7-14.
47. Rasmussen BB. Human mucinous breast carcinomas and their lymph node metastases: a histological review of 247 cases. Pathol Res Pract 1985;180:377-82.
48. Ratzenhofer M, Aubock L. The amphicrine (endo-exocrine) cells in the human gut with a short reference to amphicrine neoplasia. Acta Morphol Hung 1980;28:27-58.
49. Rosai J. Ackerman's surgical pathology. 8th ed. St Louis: CV Mosby, 1996:1590-628.
50. Rosen PP. Oberman HA. Tumors of the mammary gland. In: Atlas of Tumor Pathology, 3rd ser, fasc 7. Washington, DC: Armed Forces Institute of Pathology. 1993.
51. Santini D, Bazzocchi F, Pileri S, et al. Mammary carcinoma with argyrophilic cells: an immunohistochemical and ultrastructural study. Tumori 1985;71:331-8.
52. Schnitt SJ, Silen W, Sadowsky NL, Connolly JL, Harris JR. Ductal carcinoma in situ (intraductal carcinoma) of the breast. N Engl J Med 1988;318:888-903.
53. Seshi B, True L, Carter D, Rosai J. Immunohistochemical characterization of a set of monoclonal antibodies to human neuron-specific enolase. Am J Pathol 1988;131:258-69.
54. Silverberg SG, Kay S, Chitale AR, Levitt SH. Colloid carcinoma of the breast. Am J Clin Pathol 1971;55:355-63.
55. Silverstein MJ, Waisman JR, Gamagami P, et al. Intraductal carcinoma of the breast (208 cases): clinical factors influencing treatment choice. Cancer 1990;66:102-8.
56. Tavassoli FA. Pathology of the breast. New York: Elsevier, 1992.
57. Taxy JB, Tischler AS, Insalaco SJ, Battifora H. "Carcinoid" tumor of the breast: a variant of conventional breast cancer? Hum Pathol 1981;12:170-8.
58. Thomas P, Battifora H, Manderino GL, Patrick J. A monoclonal antibody against neuron specific enolase: immunohistochemical comparison with a polyclonal antiserum. Am J Clin Pathol 1987;88:146-52.
59. Toyoshima S. Mammary carcinoma with argyrophilic cells. Cancer 1983;52:2129-38.
60. Tsang WYW, Chan JKC, Pong WM, Yuen RWS. Endocrine ductal carcinoma-in-situ and mucoid carcinoma of the breast: the missing link? [Abstract]. Surg Pathol 1991;3:368.
61. Van de Vijver MJ, Peterse JL, Mooi WJ, et al. Neu-protein overexpression in breast cancer: association with comedotype ductal carcinoma in situ and limited prognostic value in stage II breast cancer. N Engl J Med 1988;319:1239-45.
62. Wade PM, Mills SE, Read M, Cloud W, Lambert MJ, Smith RE. Small cell neuroendocrine (oat cell) carcinoma of the breast. Cancer 1983;52:121-5.
63. Wilson BS, Lloyd RV. Detection of chromogranin in neuroendocrine cells with a monoclonal antibody. Am J Pathol 1984;115:458-68.
64. Maluf HM. Koerner FC. Solid papillary carcinoma of the breast, a form of intraductal carcinoma with endocrine differentiation frequently associated with mucinous carcinoma. Am J Surg Pathol 1995;19:1237-4.